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Role of Bile Acids in Colorectal Carcinogenesis
F.M. Nagengast, M J.A.L. Grubben and I.P. van Munster
Dietary factors are considered important environmental risk determinants for colorectal cancer development. 
Epidemiological studies have shown that a high fat (or meat) intake is associated positively and a high starch, fibre 
(non-starch polysaccharide), vegetable and fruit intake negatively with colorectal cancer incidence. One 
mechanism by which these effects are possibly exerted is through the metabolism of secondary bile acids. 
Secondary bile acids are formed after enzymatic deconjugation and dehydroxylation of primary bile acids in the 
large bowel by anaerobic bacteria. It has been shown that these compounds can have tumour-promoting capacities 
in animal experiments. In epidemiological studies, colonic cancer risk is related to the faecal bile acid 
concentration. In serum and bile of patients with colonic adenomas, more deoxycholic acid was detected than in 
healthy controls. Secondary bile acids are toxic to several cell systems at physiological concentrations. The exact 
mechanism by which these amphiphilic molecules exert their action is not well understood. It might act through 
membrane damage, intracellular mitochondrial action or genotoxic effects. So far the evidence that bile acids are 
involved in colonic carcinogenesis is largely circumstantial. It is, however, well accepted that environmental 
factors, such as dietary habits influence genetic susceptibility. Bile acids could play a promoting role in this 
process.
Key words: bile acids and salts, cytotoxicity, cell proliferation, colonic carcinogenesis, dietary factors
EurJ Cancer, Vol. 31 A, Nos 7/8, pp. 1067-1070, 1995
INTRODUCTION
The role o f dietary factors in colonic carcinogenesis
T he in c id en c e  of colorectal cancer is high in Western countries
and is related to dietary habits. Currently it is assumed that
dietary factors modulate a genetic susceptibility. In epidemiolog­
ical observations, the consumption of animal fat is positively 
related to the incidence of colon cancer [1, 2]. The intake of 
fibre is possibly negatively related to this incidence; however, 
many inconsistencies exist [3]. Migrant studies revealed that 
inhabitants moving from low-incidence to high-incidence areas 
acquired the colonic cancer risk of the region they moved to [4]. 
Within a given high-risk population, groups with different life 
styles have different colon cancer risks. Seventh Day Adventists 
in the U. S .A. have a lower incidence than the general population, 
probably because they consume a diet low in fat and high in fibre
[5]-
Fat
The hypothesis postulates that a high fat diet enhances the 
formation and degradation of bile acids and neutral sterols 
exerting a promoting effect in colonic carcinogenesis. Indeed, it 
has been found that dietary fat increases the output and faecal 
concentration of bile acids [6], Epidemiological evidence has 
shown that populations with a high incidence of colorectal cancer 
and consuming a high fat and animal protein diet, excrete about 
twice the amount of secondary bile acids [7]. The concentration
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of these bile acids is even more increased. However, other 
studies in the U.S.A., U.K. and New Zealand have failed to 
demonstrate a correlation between high fat intake and colorectal 
cancer incidence [8]. Case-control studies have shown conflict­
ing results in this respect [9].
Bile acid metabolism
Bile acids are the major end products of cholesterol metab­
olism and are synthesised in the liver. The primary bile acids 
cholic acid (CA) and chenodeoxycholic acid (CDCA) are derived 
via several intermediate steps from cholesterol and secreted in 
bile as glycine or taurine conjugates.
They serve as cholesterol solubilising agents by the formation 
of micelles, and play an important role in the digestion and 
absorption of lipids in the small intestine. More than 95% of the 
bile acids passing through the ileum are reabsorbed and return 
to the liver through the portal vein. An efficient conservation in 
the so-called enterohepatic circulation is thus achieved. The 
proportion of bile acids not absorbed in the terminal ileum is 
2-5% per cycle, and amounts to an average loss of 20% of the 
bile acid pool with 6-12 enterohepatic circulations per day. Bile 
acids that escape absorption in the ileum, are metabolised in the 
large bowel by the anaerobic bacterial flora. First, deconjugation 
takes place and the amino acid molecule on the carboxyl group 
is removed. Secondly, the primary bile acids CA and CDCA are 
dehydroxylated and converted into the secondary bile acids 
deoxycholic acid (DCA) and lithocholic acid (LCA), respect­
ively. Further bacterial degradation in the large bowel and 
alterations in the liver produce the tertiary bile acids. DC A is 
partly absorbed in the colon and enters the enterohepatic 
circulation, where it is conjugated in the liver and secreted in
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Figure 1. The entero hepatic circulation of bile acids in man.
bile; LCA is almost insoluble and very little is reabsorbed. Both 
secondary bile acids are excreted in the stool and make up to 
95% of the total amount of excreted bile acids. In the stool, the 
major part of the bile acids are bound to dietary and bacterial 
residues. In the circulating bile acid pool, CA and CDCA each 
comprise about 30-40%, DC A about 20-30% and LCA less than 
5% of the total amount [10]. Figure 1 shows the enterohepatic 
circulation of bile acids.
EXPERIMENTAL EVIDENCE
The hypothesis that the relationship between diet and colorec­
tal cancer is established through bile acid metabolism has led to 
many studies on cell systems, to experimental studies in animals 
(mostly rodents) and metabolic and interventional studies in 
humans.
Epidemiology
Colon cancer incidence is positively related to dietary fat 
intake and negatively to fibre and probably even more to total 
starch intake [11]. A high fat consumption leads to a higher bile 
acid excretion. Several epidemiological studies have shown that 
the concentration of faecal bile acids is positively related to 
colonic cancer incidence [12]. Case-control experiments, how­
ever, have shown conflicting results: in some a higher faecal bile 
acid concentration was found in patients with adenomas or 
cancer, others found no difference between cases and controls
[13].
Part of the discrepancy can be attributed to confounding 
factors, such as age and dietary consumption, which were 
not controlled for in these investigations. Faecal bile acid 
concentration proves to be age-dependent and inversely related 
to dietary fibre intake [14]. In some studies bile acid kinetics or 
biliary and serum bile acids were measured. The absorption of 
DCA from the large bowel is also age-dependent [15, 16], higher 
in adenoma patients than in age-matched controls, and coincides 
with a more anaerobic environment [17, 18]. One study showed 
a higher biliary CDCA fraction in adenoma and carcinoma 
patients [19], Recently it was demonstrated that adenoma pati­
ents have a higher serum DCA concentration than healthy 
controls [20, 21].
Animal experiments
Secondary bile acids can act as tumour promoters in animal 
experiments, which are ideally performed in rodents. Because 
spontaneous colon cancer rarely occurs in rodents, initiating 
carcinogens such as azoxymethane have to be used [13]. Studies 
have been performed both by dietary manipulation (fat and 
fibre) and by direct application of bile acids to the colonic 
mucosa. Feeding high fat diets resulted in a higher tumour yield 
and an increased faecal bile acid concentration. Fibre addition 
has an opposite effect, although results were conflicting in this 
respect [13]. After diversion of bile ducts or small bowel resection 
more tumours can occur [22]. Direct installation of bile acids in 
the large bowel can be tumour promoting [23]. In one study, 
infusion of DCA led to damage of the mucosa thereby provoking
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an increased cell renewal. This was accomplished by increased 
cell proliferation which might be the key mechanism in the effect 
of bile acids in colonic carcinogenesis [24]. From this and other 
experiments, the concept has emerged that the concentration of 
soluble bile acids rather than the total faecal bile acid concen­
tration determines possible cytotoxic effects of these molecules. 
The former is reflected by the concentration in the aqueous 
phase of the stool.
Genotoxicity and mutagenicity
Secondary bile acids can have co-mutagenic effects as has been 
shown in the Ames test [25]. It has also been demonstrated that 
LCA can transform hamster embryo cells in culture, LCA can 
break DNA strands in cultured L1210 cells and enhance the 
activity of repair mechanisms after DNA strand breakage caused 
by 2-aminoanthracene [26, 27].
Both LCA and DCA stimulated the incorporation of tritiated 
thymidine in mouse liver and biliary tract epithelium, suggestive 
of enhanced cell proliferation [28]. Among components con­
tributing to faecal mutagenicity are reactive glyceryl ethers, 
known as fecapentaenes. Their biosynthesis might be stimulated 
by bile salts [29]. In general conjugated bile salts have less or no 
genotoxic effects and unconjugated dihydroxy and mono- 
hydroxy bile salts are more genotoxic. However, it must be kept 
in mind that the most abundant monohydroxy bile acid in the 
human colonic lumen, LCA, is very poorly soluble in water.
Cytotoxicity o f bile acids 
Damaging effects of various bile acids on the colonic mucosa 
have been described at the concentrations present in the aqueous 
phase of stool [24]. Bile acids can disrupt the integrity of the cell 
membrane of colonic mucosal cells [24, 30-32]. The increased 
cell loss will stimulate a compensatory cell renewal by increased 
mucosal proliferation. Thus, dietary manipulation resulting in a 
rise in colonic bile acid concentration can cause increased 
mucosal proliferation [33, 34]. In addition to the attractive 
hypothesis that hyperproliferation is induced by the cytotoxic 
potential of bile acids, there is also evidence of a direct stimu­
latory effect of several bile acids on proliferation. Bile salts 
(DCA) can release prostaglandin E2 (PGE2) from colonic tissues. 
The proliferative activity of colonic epithelial cells is among 
other things suppressed by PGE2. Bile salts can enhance the 
release of arachidonate from colonocytes and subsequently the 
synthesis of PGE2. This could be another explanation of the link 
between cell proliferation and bile acids [35]. A third effect 
could be on a family of enzymes within the cell membrane 
known as protein kinases. Protein kinase C appears to play a 
critical role in tumour promotion and in the action of growth 
factors [36]. Bile acids might have a direct stimulatory effect on 
subclasses of these enzymes [37].
Bile Acids in Colorectal Carcinogenesis 1069
Recently, a putative mechanism of hepatocyte necrosis was 
published. Toxic bile salts (in the liver GCDC) impair mitochon­
drial function, leading to an inhibition of oxidative phosphoryl­
ation and enhanced formation of toxic oxygen species by the 
mitochondrial respiratory chain. This results in oxidative stress 
and ATP depletion causing an increase in Ca2+ concentration 
with stimulation of hydrolases. This could lead to hydrolysis of 
lipid membranes and structural proteins causing cell death by 
necrosis [38],
We do not know whether this mechanism could be operative 
in colonocytes, since the type of cell and amount of cytotoxic 
bile salts differs considerably from the liver, but it remains an 
attractive hypothesis for cytotoxicity. Indirect evidence that 
this mechanism might also be applicable to cells other than 
hepatocytes, comes from experiments in which cytotoxicity of 
bile salts is determined in colon cancer cell lines (HT-29., CACO- 
2). In these cell lines cytotoxicity can be measured by the MTT 
assay* in which the mitochondrial function of the cell is tested. 
In viable cells MTT (3-(4,5~dimethylthizol-2-yl)-2,5-diphenyl 
tetrazolium bromide) is converted by the mitochondria to forma- 
zan, a blue dye, which can be detected in a fluorometer. With 
this assay, we and others have shown that the unconjugated 
dihydroxy bile acids DCA and CDCA are cytotoxic in a range 
that can be found in faecal water [32, 39]. Conjugated dihydroxy 
bile acids and cholic acid are not cytotoxic in this assay. So, as 
stated previously, the bile acid-induced increase in mucosal 
proliferation may be the key step in the association between bile 
acids and colon carcinogenesis. It has been demonstrated that 
a hyperproliferative colonic mucosa is more susceptible to 
carcinogens than a quiescent mucosa [40-42],
When proliferation is increased, the fraction of cells in S- 
phase (target cells) is relatively high, possibly resulting in an 
increased potency of intraluminal mutagenic substances. Large 
bowel neoplasms are associated with changes in proliferative 
characteristics, and in patients with colonic adenomas and 
cancer, an overall increased colonic mucosal proliferation has 
been demonstrated [43], Furthermore, the proliferative com­
partment expands from the basal part of the crypts to the luminal 
surface. Similar changes in proliferative acitivity can be seen in 
patients with familial adenomatous polyposis, who are at high 
risk of developing colonic cancer. So, within the 
adenoma-carcinoma sequence, hyperproliferation might be a 
relatively early event leading towards an increased susceptibility 
to colonic cancer. Bile acids possibly play an important inter­
mediate role in this process. It has to be kept in mind, however, 
that many other factors contribute to this cascade of events. 
Most intriguing, of course, are the successive genetic events that 
occur in the adenoma-carcinoma sequence [44]. In Figure 2, 
a hypothesis of colonic carcinogenesis is shown with special 
reference to the role of bile acids.
CONCLUSIONS
Bile acids (salts) are amphiphilic molecules synthesised in the 
liver from cholesterol. They play an important role in the 
solubility of cholesterol in bile and in the digestive process in 
the small bowel through formation of micelles. An effective 
enterohepatic circulation keeps most of these bile acids within 
the body. During every cycle approximately 5% of the primary 
bile acids are lost into the large bowel. Here extensive degra­
dation by the anaerobic flora occurs. The main events are 
deconjugation and dehydroxylation leading to the formation of 
unconjugated secondary bile acids. These last compounds have 
been incriminated in colonic carcinogenesis. Thus far, evidence
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Figure 2. Hypothesis for the role of bile acids in colonic carcino
genesis.
is largely circumstantial and is derived from epidemiological and 
experimental studies in both animals and humans. Bile acids are 
probably cytotoxic to colonocytes and lead to a compensatory 
cell proliferation. The mechanism of cytotoxicity is not well 
understood, but can be attributed to membrane as well as 
intracellular effects. The increase in colonic cell proliferation is 
probably one of the key steps in the risk of development of 
colorectal cancer. Further studies are necessary to elucidate the 
mechanisms which are involved in the interaction of luminal 
events with the cascade of genetic changes that occur within the 
colonic mucosa during colonic carcinogenesis.
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